Bombay HC backs GSK in Paxil trademark row against Shreya Life Sciences
MUMBAI: The Bombay High Court has ruled in favour of listed biopharma company GSK Group (formerly GlaxoSmithKline Pharmaceuticals), which had sought cancellation of the registration of the mark 'Paxil' by Mumbai-based pharmaceutical firm Shreya Life Sciences Pvt Ltd. The Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
